Skip to main content
NeuronFeed

Genesis Therapeutics · Series B

Amount

$200M

Round

Series B

Valuation

—

Announced

—

Investors

Participating investors

Menlo Ventures Fidelity Management & Research Radical Ventures BlackRock NVentures Andreessen Horowitz (Bio + Health)

Other Genesis Therapeutics rounds

Date Round Amount
May 2026 Strategic Equity Investment $40M Details →